Participate in a Psychedelic Medicine Clinical Trial | NYU Langone Health
Learn more about participating in clinical trials being conducted by NYU Langone’s Center for Psychedelic Medicine.
Center for Psychedelic Medicine Team | NYU Langone Health
Meet NYU Langone’s Center for Psychedelic Medicine team, comprising leaders in the field.
The Psychedelic Revolution Is Coming
Dr. Michael B. Bogenschutz, director of NYU Langone’s Center for Psychedelic Medicine, explains the growing interest in psychedelic research.
Psychedelic Drug Therapy May Help Treat Alcohol Addiction
NYU Langone study shows that 2 doses of psilocybin combined with psychotherapy reduces alcohol consumption by 83 percent among heavy drinkers.
Staff bios
... Department of Psychiatry \. NYU Langone '--Health Center for Psychedelic Medicine Bios DC 01242025 ... Michael Bogenschutz, MD Dr. Bogenschutz is the Director of the NYU Langone Center for Psychedelic Medicine ...
Psychedelic Drug Benefits Persist in People with Cancer
NYU Langone study finds a psychedelic drug improved emotional distress in people with cancer for nearly five years after treatment.
Podcast: How the Pandemic Has Changed These Doctors
Three NYU Langone doctors discuss the impact of the COVID-19 pandemic on healthcare and new advances in their fields.
NYU Langone Health in the News — July 14, 2023
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from July 14, 2023.
NYU Langone Health in the News— Wednesday 25, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from June 25, 2025.
Psychiatry Continuing Medical Education | NYU Langone Health
NYU Langone’s Department of Psychiatry offers continuing medical education courses on the latest advances in mental health care and research.